HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation CyclophosphamideLeo Luznik, Ephraim J. Fuchs, Paul V. O’Donnell et al.|Biology of Blood and Marrow Transplantation|2008Cited by 1.9k
Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHDBenjamin Watkins, Leslie S. Kean, Ted Gooley et al.|Journal of Clinical Oncology|2021Cited by 247
Azithromycin Use and Increased Cancer Risk among Patients with Bronchiolitis Obliterans after Hematopoietic Cell TransplantationGuang‐Shing Cheng, Anne Bergeron, Louise Bondeelle et al.|Biology of Blood and Marrow Transplantation|2019Cited by 39
HA-1–targeted T-cell receptor T-cell therapy for recurrent leukemia after hematopoietic stem cell transplantationElizabeth F. Krakow, Marie Bleakley, Michelle Brault et al.|Blood|2024Cited by 29
Fatigue in Hematopoietic Cell Transplantation Survivors: Correlates, Care Team Communication, and Patient-Identified Mitigation StrategiesChristina Ullrich, William A. Wood, Kelsey K. Baker et al.|Transplantation and Cellular Therapy|2022Cited by 13